| Outcome of advanced renal cell carcinoma arising in end-stage renal disease: comparison with sporadic renal cell carcinoma | Clinical and Experimental Nephrology | 1 day | save |  |  |  |  |
| Physical activity in patients with pre‑dialysis chronic kidney disease is associated with decreased renal function | Clinical and Experimental Nephrology | 3 days | save | | | | |
| Mesangial C3 deposition and serum C3 levels predict renal outcome in IgA nephropathy | Clinical and Experimental Nephrology | 5 days | save | | | | |
| Renal morphology and function from childhood to adulthood in Turner syndrome | Clinical and Experimental Nephrology | 5 days | save | | | | |
| Kidney biopsy guidebook 2020 in Japan | Clinical and Experimental Nephrology | 9 days | save | | | | |
| Deletion of Alox15 improves kidney dysfunction and inhibits fibrosis by increased PGD 2 in the kidney | Clinical and Experimental Nephrology | 11 days | save | | | | |
| Impact of visceral fat area in patients with chronic kidney disease | Clinical and Experimental Nephrology | 11 days | save | | | | |
| A cross-sectional study in patients with IgA nephropathy of correlations between clinical data and pathological findings at the time of renal biopsy: a Japanese prospective cohort study | Clinical and Experimental Nephrology | 11 days | save | | | | |
| Safety and effectiveness of everolimus in maintenance kidney transplant patients in the real-world setting: results from a 2-year post-marketing surveillance study in Japan | Clinical and Experimental Nephrology | 16 days | save | | | | |
| Clinical characteristics of COVID-19 infection in a dialysis center during a nosocomial outbreak | Clinical and Experimental Nephrology | 20 days | save | | | | |
| Association of serum lncRNA H19 expression with inflammatory and oxidative stress markers and routine biochemical parameters in chronic kidney disease | Clinical and Experimental Nephrology | 22 days | save | | | | |
| Valganciclovir prophylaxis for cytomegalovirus infection in pediatric kidney transplant recipients: a single-center experience | Clinical and Experimental Nephrology | 32 days | save | | | | |
| Early cardiovascular events and cardiovascular death after renal transplantation: role of pretransplant risk factors | Clinical and Experimental Nephrology | 32 days | save | | | | |
| Incidence and risk factors of acute kidney injury, and its effect on mortality among Japanese patients receiving immune check point inhibitors: a single-center observational study | Clinical and Experimental Nephrology | 39 days | save | | | | |
| Preservation of kidney function irrelevant of total kidney volume growth rate with tolvaptan treatment in patients with autosomal dominant polycystic kidney disease | Clinical and Experimental Nephrology | 39 days | save | | | | |
| Effects of phospholipase A 2 receptor and thrombospondin type-1 domain-containing 7A expression in glomerular basement membranes on treatment response and renal outcome in membranous nephropathy | Clinical and Experimental Nephrology | 41 days | save | | | | |
| Association between urine pH and risk of contrast-associated acute kidney injury among patients after emergency percutaneous coronary intervention: a V-shape relationship? | Clinical and Experimental Nephrology | 48 days | save | | | | |
| Correction to: The clinical usage of liposomal amphotericin B in patients receiving renal replacement therapy in Japan: a nationwide observational study | Clinical and Experimental Nephrology | 51 days | save | | | | |
| Hematuria, bone health, and cardiovascular mortality | Clinical and Experimental Nephrology | 51 days | save | | | | |
| Association between serum potassium levels and adverse outcomes in chronic kidney disease: the Fukushima CKD cohort study | Clinical and Experimental Nephrology | 52 days | save | | | | |
| Improving hepatitis B vaccination rates for advanced chronic kidney disease patients: a quality improvement initiative | Clinical and Experimental Nephrology | 52 days | save | | | | |
| Clinical characteristics of patients with early relapse during B-cell depletion after rituximab treatment for complicated steroid-dependent nephrotic syndrome | Clinical and Experimental Nephrology | 53 days | save | | | | |
| Renal capsular vein thrombosis | Clinical and Experimental Nephrology | 55 days | save | | | | |
| Relationship between serum lipid concentrations and impaired renal function in patients with chronic kidney disease: the Fukuoka Kidney Disease Registry Study | Clinical and Experimental Nephrology | 55 days | save | | | | |
| Validation of the diagnostic criteria for IgG4-related kidney disease (IgG4-RKD) 2011, and proposal of a new 2020 version | Clinical and Experimental Nephrology | 55 days | save | | | | |
| Impact of water consumption on renal function in the general population: a cross-sectional analysis of KNHANES data (2008–2017) | Clinical and Experimental Nephrology | 55 days | save | | | | |
| Clinical and morphologic spectrum of renal involvement in idiopathic hypereosinophilic syndrome | Clinical and Experimental Nephrology | 55 days | save | | | | |
| Calcified cerebral embolism due to aortic valve calcification | Clinical and Experimental Nephrology | 152 days | save | | | | |
| Serum levels of galactose-deficient IgA1 in Chinese children with IgA nephropathy, IgA vasculitis with nephritis, and IgA vasculitis | Clinical and Experimental Nephrology | 166 days | save | | | | |
| Zebra bodies without Fabry disease or hydroxychloroquine | Clinical and Experimental Nephrology | 170 days | save | | | | |
| Intravenous administration of Streptococcus mutans induces IgA nephropathy-like lesions | Clinical and Experimental Nephrology | 172 days | save | | | | |
| Impact of the number of steroid pulses in tonsillectomy combined with steroid pulse therapy: a nationwide retrospective study in Japan | Clinical and Experimental Nephrology | 178 days | save | | | | |
| Renal tubular injury by glyphosate-based herbicide | Clinical and Experimental Nephrology | 180 days | save | | | | |
| Association between urinary salt excretion and albuminuria in Japanese patients with chronic kidney disease: the Fukuoka kidney disease registry study | Clinical and Experimental Nephrology | 183 days | save | | | | |
| Effects of LDL apheresis on proteinuria in patients with diabetes mellitus, severe proteinuria, and dyslipidemia | Clinical and Experimental Nephrology | 184 days | save | | | | |
| The risk of nephrotic syndrome with non-VEGF inhibitory antineoplastic drugs: from viewpoint of the adverse event reports in Japan | Clinical and Experimental Nephrology | 185 days | save | | | | |
| Factors affecting patency of arteriovenous fistula following first percutaneous transluminal angioplasty | Clinical and Experimental Nephrology | 185 days | save | | | | |
| Sclerostin is an independent risk factor for all-cause mortality in kidney transplant recipients | Clinical and Experimental Nephrology | 192 days | save | | | | |
| Association between circulating tumor necrosis factor receptors and oral bacterium in patients receiving hemodialysis: a cross-sectional study | Clinical and Experimental Nephrology | 192 days | save | | | | |
| Safety and efficacy of etelcalcetide, an intravenous calcimimetic, for up to 52 weeks in hemodialysis patients with secondary hyperparathyroidism: results of a post-marketing surveillance in Japan | Clinical and Experimental Nephrology | 192 days | save | | | | |
| Nomenclature for kidney function and disease: executive summary and glossary from a Kidney Disease: Improving Global Outcomes (KDIGO) consensus conference | Clinical and Experimental Nephrology | 193 days | save | | | | |
| | 
report | |
| |
